Our evaluation of the differences in tumor-associated pathway scores between the two subtypes revealed that the C2 cluster was significantly enriched in the HIPPO, MYC, NOTCH, NRF1, TGF-beta, PIK3, RAS and TP53 pathways (Fig. 2D). The gene discussed is PIK3CG; the disease is neoplasm.